Global Human Microbiome Market: Emerging Trends, Major Key Players ENTEROME Bioscience (France) and Seres Therapeutics (US)

According to the report, The global Human Microbiome market size is expected to reach $2061.94 Billion by 2028 growing at the CAGR of 42.59% from 2025 to 2028. The major factor driving the growth of the Human Microbiome Market is the rising geriatric population in countries such as China and India, due to poor sanitation conditions. In addition, the increasing prevalence of lifestyle-related diseases such as obesity and diabetes, among others, is an important factor driving the growth of the market.
"The human microbiome market is expected to emerge as a promising market, and the market for diagnostic platforms for human microbiome is expected to grow at the highest CAGR over the forecast period."

Request Free Sample Report or PDF Copy: https://report.evolvebi.com/index.php/sample/request?referer=OpenPR&reportCode=006068

The latest research report published by Evolve Business Intelligence examines the impacts of numerous market aspects on the global HUMAN MICROBIOME industry including a look at the current market size and forecasts for key segments and regions, the driving forces behind the market, the probable effects from key trends, how all these will affect the business plan, SWOT analysis of critical sectors for each of the key competitors, customers and more! Providing valuable data about conglomerations that are most likely going to have an impact on this industry is essential to any company who plans to properly invest for next 5 years. These findings supplement our initial quantitative study in order to facilitate any new investments or planning traits against threats in existing sectors through a strategic business plan.

Impact of COVID-19

The on-going COVID-19 pandemic has had a significant impact on the industry. Several financial impacts and disruptions have been felt over a long period of time. Our research has interviewed numerous delegates from this industry, across geographical markets to collect information that is helpful for addressing potential challenges the COVID-19 pandemic may cause going forward.
In terms of COVID 19 impact, the Human Microbiome market report also includes the following data points:
• Impact of COVID-19
• Government Aids and Policies for Industry Revival
• Companies Recent Developments to Tackle Negative Impact
• Opportunity Window & Post COVID Trend

For Any Query or Customization, Ask Our Industry Experts@ https://report.evolvebi.com/index.php/sample/request?referer=OpenPR&reportCode=006068

Key Players
Some of the major Human Microbiome players holding highest market share include ENTEROME Bioscience (France), Seres Therapeutics (US), 4D Pharma (UK) and Ferring Pharmaceuticals (Switzerland) These players use acquisition as a key strategy to gain significant market share to compete with market leaders.

The key players profiled in the report are:
● ENTEROME Bioscience (France)
● Seres Therapeutics (US)
● 4D Pharma (UK)
● Ferring Pharmaceuticals (Switzerland)
● ViThera Pharmaceuticals (US)
● Second Genome (US)
● Vedanta BioSciences (US)
● Synlogic (US)

Segmental Analysis

Market Segment By Product with focus on market share, consumption trend, and growth rate of HUMAN MICROBIOME Market:
o Prebiotics
o Probiotics
o Food
o Diagnostic Tests
o Drugs

Market Segment By Applications with focus on market share, consumption trend, and growth rate of HUMAN MICROBIOME Market:
o Therapeutic
o Diagnostic

Market Segment By Disease with a focus on market share, consumption trend, and growth rate of HUMAN MICROBIOME Market:
o Infectious
o Metabolic/Endocrine

For more information: https://report.evolvebi.com/index.php/sample/request?referer=OpenPR&reportCode=006068

Global Human Microbiome Geographic Coverage:
• North America
o US
o Canada

• Europe
o UK
o Germany
o France
o Italy
o Spain
o Rest of Europe

• Asia Pacific
o China
o Japan
o India
o South Korea
o Indonesia
o Malaysia
o Rest of Asia Pacific

• Latin America
o Mexico
o Brazil
o Argentina
o Rest of Latin America

• Middle East & Africa
o Saudi Arabia
o UAE
o Egypt
o South Africa
o Rest of MEA

Address
Evolve Business Intelligence
C-218, 2nd floor, M-Cube
Gujarat 396191
India

Contact: +1 773 644 5507 / +91 635 396 3987
Email: sales@evolvebi.com
Website: https://evolvebi.com/

About EvolveBI
Evolve Business Intelligence is a market research, business intelligence, and advisory firm providing innovative solutions to challenging pain points of a business. Our market research reports include data useful to micro, small, medium, and large-scale enterprises. We provide solutions ranging from mere data collection to business advisory.

Evolve Business Intelligence is built on account of technology advancement providing highly accurate data through our in-house AI-modelled data analysis and forecast tool – EvolveBI. This tool tracks real-time data including, quarter performance, annual performance, and recent developments from fortune’s global 2000 companies.

This release was published on openPR.